Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGEN CORPNEOG · Entity 4338 | Director | October 01, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGEN CORP
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table I · non-derivative | Direct | 28,921 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 9,804 · Balance 28,921 F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants |
| Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.24 · Expires 2036-10-01 | Direct | 20,558 |
Reported balance
After 2026-10-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-01 · Grant · Acquired 20,558 · Balance 20,558 F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants |
Filing footnotes · ownership attribution and instrument terms
F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 2, 2026 21:19 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantCommon Stock (Right to Buy) · Derivative | 20,558 | $0.00 Strike: $12.24 | $0.00 |
DisclosureSEC source: 0000711377-26-000028 · primary_doc.xml · derivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,558 Underlying: Common Stock · 20,558 shares Expires 2036-10-01 F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 01, 2026 Filed Oct 2, 2026 21:19 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantRestricted Stock Units | 9,804 | $12.24 | $120,000.96 |
DisclosureSEC source: 0000711377-26-000028 · primary_doc.xml · nonDerivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,921 F1 · shares: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 19:39 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 1,777 | $6.19 Strike: $6.19 | $10,999.63 |
DisclosureSEC source: 0000711377-25-000066 · primary_doc.xml · derivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,777 Underlying: Common Stock · 1,777 shares Expires 2025-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 19:39 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 1,777 | $6.19 | $10,999.63 |
DisclosureSEC source: 0000711377-25-000066 · primary_doc.xml · nonDerivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2025 Filed Oct 27, 2025 20:23 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantCommon Stock (Right to Buy) · Derivative | 50,814 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0000711377-25-000056 · primary_doc.xml · derivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,814 Underlying: Common Stock · 50,814 shares Expires 2035-10-23 F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 23, 2025 Filed Oct 27, 2025 20:23 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantCommon Stock | 19,769 | $6.07 | $119,997.83 |
DisclosureSEC source: 0000711377-25-000056 · primary_doc.xml · nonDerivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,084 F1 · shares: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:03 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 2,071 | $5.63 Strike: $5.63 | $11,659.73 |
DisclosureSEC source: 0000711377-25-000042 · primary_doc.xml · derivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,071 shares Expires 2025-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:03 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 2,071 | $5.63 | $11,659.73 |
DisclosureSEC source: 0000711377-25-000042 · primary_doc.xml · nonDerivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2025 Filed Apr 25, 2025 20:32 UTC | NEOGEN CORP NEOG · Entity 4338 | PurchaseCommon Stock | 5,770 | $5.17 | $29,830.90 |
DisclosureSEC source: 0000711377-25-000012 · primary_doc.xml · nonDerivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,244 Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 18:06 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 1,776 | $13.81 Strike: $13.81 | $24,526.56 |
DisclosureSEC source: 0000711377-24-000056 · primary_doc.xml · derivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,552 Underlying: Common Stock · 1,776 shares Expires 2024-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 18:06 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 1,776 | $13.81 | $24,526.56 |
DisclosureSEC source: 0000711377-24-000056 · primary_doc.xml · nonDerivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2024 Filed Oct 28, 2024 14:59 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantCommon Stock (Right to Buy) · Derivative | 18,653 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0000711377-24-000044 · primary_doc.xml · derivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,653 Underlying: Common Stock · 18,653 shares Expires 2031-10-24 F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 24, 2024 Filed Oct 28, 2024 14:59 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantRestricted Stock Units | 6,075 | $13.58 | $82,498.50 |
DisclosureSEC source: 0000711377-24-000044 · primary_doc.xml · nonDerivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,397 F1 · shares: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 07, 2024 Filed Oct 9, 2024 16:08 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 236 | $14.89 Strike: $14.89 | $3,514.04 |
DisclosureSEC source: 0000711377-24-000027 · primary_doc.xml · derivative · entry 4 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 236 shares Expires 2024-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2024 Filed Oct 9, 2024 16:08 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 2,070 | $15.07 Strike: $15.07 | $31,194.90 |
DisclosureSEC source: 0000711377-24-000027 · primary_doc.xml · derivative · entry 3 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,071 Underlying: Common Stock · 2,070 shares Expires 2024-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2024 Filed Oct 9, 2024 16:08 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 236 | $14.89 | $3,514.04 |
DisclosureSEC source: 0000711377-24-000027 · primary_doc.xml · nonDerivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2024 Filed Oct 9, 2024 16:08 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 2,070 | $15.07 | $31,194.90 |
DisclosureSEC source: 0000711377-24-000027 · primary_doc.xml · nonDerivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2023 Filed Oct 31, 2023 20:38 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 5,329 | $0.00 Strike: $15.48 | $0.00 |
DisclosureSEC source: 0000711377-23-000028 · primary_doc.xml · derivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,706 Underlying: Common Stock · 5,329 shares Expires 2026-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 26, 2023 Filed Oct 31, 2023 20:38 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 13,716 | $0.00 Strike: $15.48 | $0.00 |
DisclosureSEC source: 0000711377-23-000028 · primary_doc.xml · derivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,883 Underlying: Common Stock · 13,716 shares Expires 2030-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 20:58 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 6,212 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000711377-22-000022 · primary_doc.xml · derivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,968 Underlying: Common Stock · 6,212 shares Expires 2025-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 20:58 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 18,416 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000711377-22-000022 · primary_doc.xml · derivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,167 Underlying: Common Stock · 18,416 shares Expires 2029-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 22:00 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 707 | $0.00 Strike: $42.45 | $0.00 |
DisclosureSEC source: 0000711377-21-000029 · primary_doc.xml · derivative · entry 2 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,273 Underlying: Common Stock · 707 shares Expires 2024-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: RSUs vest in three equal annual installments, on each of the first three anniversary dates of the grant Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 22:00 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 2,971 | $0.00 Strike: $42.45 | $0.00 |
DisclosureSEC source: 0000711377-21-000029 · primary_doc.xml · derivative · entry 1 Woteki Catherine E · CIK 0001829079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,651 Underlying: Common Stock · 2,971 shares Expires 2026-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options have five year lives, and vest in three equal annual installments on each of the first three anniversary dates of the grant Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.